(+)-catechin multiple interactions ISO RGD:628748 6480464 Catechin inhibits the reaction [Dietary Fats results in decreased expression of ADIPOQ protein] CTD PMID:23365609 (+)-schisandrin B multiple interactions ISO RGD:628748 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of ADIPOQ mRNA] CTD PMID:31150632 (R)-carnitine increases expression ISO RGD:628748 6480464 Carnitine results in increased expression of ADIPOQ protein CTD PMID:30256492 (R)-lipoic acid increases expression ISO RGD:628748 6480464 Thioctic Acid results in increased expression of ADIPOQ mRNA, Thioctic Acid results in increased expression of ADIPOQ protein CTD PMID:22664981 (R)-lipoic acid multiple interactions ISO RGD:628748 6480464 Thioctic Acid inhibits the reaction [Dietary Fats results in decreased expression of ADIPOQ mRNA], Thioctic Acid inhibits the reaction [Dietary Fats results in decreased expression of ADIPOQ protein] CTD PMID:22664981 17alpha-ethynylestradiol increases expression ISO RGD:628748 6480464 Ethinyl Estradiol results in increased expression of ADIPOQ mRNA CTD PMID:17557909 17alpha-ethynylestradiol decreases expression EXP 6480464 Ethinyl Estradiol results in decreased expression of ADIPOQ mRNA CTD PMID:18936297 17alpha-hydroxyprogesterone multiple interactions EXP 6480464 17-alpha-Hydroxyprogesterone inhibits the reaction [[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of and results in increased secretion of ADIPOQ protein] CTD PMID:29782964 17beta-estradiol decreases expression ISO RGD:1552054 6480464 Estradiol results in decreased expression of ADIPOQ mRNA, Estradiol results in decreased expression of ADIPOQ protein CTD PMID:16643890 , PMID:25859628 17beta-estradiol multiple interactions EXP 6480464 ADIPOQ protein promotes the reaction [IGF1 protein results in increased abundance of Estradiol] CTD PMID:19081562 17beta-estradiol increases expression ISO RGD:628748 6480464 Estradiol results in increased expression of ADIPOQ mRNA CTD PMID:17010207 2,2',4,4',5,5'-hexachlorobiphenyl decreases expression EXP 6480464 2 more ... CTD PMID:23146750 2,2',4,4',5,5'-hexachlorobiphenyl decreases expression ISO RGD:1552054 6480464 2 more ... CTD PMID:31449830 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO RGD:1552054 6480464 [2 more ... CTD PMID:23618531 more ... 2,2',4,4'-Tetrabromodiphenyl ether increases expression ISO RGD:628748 6480464 2 more ... CTD PMID:27291303 2,2',4,4'-Tetrabromodiphenyl ether decreases expression EXP 6480464 2 more ... CTD PMID:23146750 2,2',5,5'-tetrachlorobiphenyl affects expression EXP 6480464 2 more ... CTD PMID:21703328 2,2',5,5'-tetrachlorobiphenyl multiple interactions ISO RGD:1552054 6480464 [2 more ... CTD PMID:25510870 2,2'-Dihydroxy-4-methoxybenzophenone multiple interactions EXP 6480464 dioxybenzone promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ mRNA], dioxybenzone promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ protein] CTD PMID:32407875 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1552054 6480464 orientin inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of ADIPOQ protein], Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ mRNA] CTD PMID:16054899 , PMID:32044341 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1552054 6480464 Tetrachlorodibenzodioxin results in decreased expression of ADIPOQ protein CTD PMID:32044341 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of ADIPOQ mRNA CTD PMID:28011154 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1552054 6480464 Tetrachlorodibenzodioxin results in increased expression of ADIPOQ mRNA CTD PMID:22977169 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1552054 6480464 Tetrachlorodibenzodioxin affects the expression of ADIPOQ mRNA CTD PMID:21570461 2,4-dibromophenyl 2,4,5-tribromophenyl ether multiple interactions ISO RGD:1552054 6480464 2 more ... CTD PMID:30903904 2,4-dibromophenyl 2,4,5-tribromophenyl ether increases expression ISO RGD:1552054 6480464 2 more ... CTD PMID:30903904 2-amino-2-deoxy-D-glucopyranose increases expression ISO RGD:1552054 6480464 Glucosamine results in increased expression of ADIPOQ mRNA CTD PMID:15694357 2-amino-2-deoxy-D-glucopyranose increases expression ISO RGD:628748 6480464 Glucosamine results in increased expression of ADIPOQ mRNA CTD PMID:15694357 2-butoxyethanol decreases expression ISO RGD:1552054 6480464 n-butoxyethanol results in decreased expression of ADIPOQ mRNA CTD PMID:19812364 2-deoxy-D-glucose multiple interactions EXP 6480464 Indinavir inhibits the reaction [ADIPOQ protein modified form results in increased uptake of Deoxyglucose] CTD PMID:29991592 2-deoxy-D-glucose increases uptake EXP 6480464 ADIPOQ protein modified form results in increased uptake of Deoxyglucose CTD PMID:29991592 3',5'-cyclic AMP increases abundance EXP 6480464 ADIPOQ protein results in increased abundance of Cyclic AMP CTD PMID:18931039 3,3',4,4',5-pentachlorobiphenyl affects expression EXP 6480464 3 more ... CTD PMID:21703328 3,3',4,4',5-pentachlorobiphenyl increases secretion ISO RGD:1552054 6480464 3 more ... CTD PMID:33026256 3,3',4,4',5-pentachlorobiphenyl decreases expression ISO RGD:1552054 6480464 3 more ... CTD PMID:33026256 3,3',4,4',5-pentachlorobiphenyl increases expression ISO RGD:628748 6480464 3 more ... CTD PMID:29474705 3,3',4,4',5-pentachlorobiphenyl decreases expression EXP 6480464 3 more ... CTD PMID:23146750 , PMID:25304490 3,3',4,4',5-pentachlorobiphenyl multiple interactions EXP 6480464 2-methyl-2H-pyrazole-3-carboxylic acid 2-methyl-4-o-tolylazophenylamide inhibits the reaction [3 more ... CTD PMID:25304490 3,3',4,4'-tetrachlorobiphenyl decreases expression ISO RGD:1552054 6480464 3 more ... CTD PMID:21925196 3,3',5,5'-tetrabromobisphenol A increases expression ISO RGD:1552054 6480464 tetrabromobisphenol A results in increased expression of ADIPOQ mRNA CTD PMID:30496566 3,4-methylenedioxymethamphetamine increases methylation ISO RGD:1552054 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in increased methylation of ADIPOQ promoter CTD PMID:26251327 3,4-methylenedioxymethamphetamine increases expression ISO RGD:1552054 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in increased expression of ADIPOQ mRNA CTD PMID:26251327 3-aminobenzamide increases expression ISO RGD:628748 6480464 3-aminobenzamide results in increased expression of ADIPOQ mRNA CTD PMID:18815186 3-aminobenzamide increases expression ISO RGD:1552054 6480464 3-aminobenzamide results in increased expression of ADIPOQ mRNA CTD PMID:18815186 3-aminobenzamide increases expression EXP 6480464 3-aminobenzamide results in increased expression of ADIPOQ mRNA CTD PMID:18815186 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1552054 6480464 2 more ... CTD PMID:16054899 more ... 3-isobutyl-1-methyl-7H-xanthine decreases expression EXP 6480464 1-Methyl-3-isobutylxanthine results in decreased expression of ADIPOQ mRNA CTD PMID:22645054 3-isobutyl-1-methyl-7H-xanthine multiple interactions EXP 6480464 17 alpha-Hydroxyprogesterone Caproate inhibits the reaction [[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of and results in increased secretion of ADIPOQ protein] more ... CTD PMID:19186324 more ... 4,4'-sulfonyldiphenol increases expression EXP 6480464 bis4-hydroxyphenylsulfone results in increased expression of ADIPOQ mRNA CTD PMID:27685785 4,4'-sulfonyldiphenol increases expression ISO RGD:1552054 6480464 bis4-hydroxyphenylsulfone results in increased expression of ADIPOQ mRNA CTD PMID:30959087 4-methylumbelliferone multiple interactions ISO RGD:1552054 6480464 Hymecromone inhibits the reaction [Dietary Fats results in decreased expression of ADIPOQ protein] CTD PMID:24661945 4-nonylphenol increases expression ISO RGD:628748 6480464 4-nonylphenol results in increased expression of ADIPOQ protein CTD PMID:24388992 5,6,7,8-tetrahydrobiopterin multiple interactions ISO RGD:628748 6480464 sapropterin inhibits the reaction [Fructose results in decreased expression of ADIPOQ mRNA], sapropterin inhibits the reaction [Fructose results in decreased expression of ADIPOQ protein] CTD PMID:17098227 5-(2-chloroethyl)-4-methylthiazole multiple interactions ISO RGD:1552054 6480464 Chlormethiazole inhibits the reaction [Ethanol results in decreased expression of ADIPOQ] CTD PMID:25162931 [6]-Shogaol multiple interactions ISO RGD:1552054 6480464 2-chloro-5-nitrobenzanilide inhibits the reaction [shogaol results in increased expression of ADIPOQ mRNA], shogaol inhibits the reaction [TNF protein results in decreased expression of and results in decreased secretion of ADIPOQ protein] CTD PMID:18577375 [6]-Shogaol increases expression ISO RGD:1552054 6480464 shogaol results in increased expression of ADIPOQ mRNA CTD PMID:18577375 acarbose increases expression ISO RGD:628748 6480464 Acarbose results in increased expression of ADIPOQ protein CTD PMID:18290871 acetaldehyde multiple interactions EXP 6480464 ADIPOQ protein inhibits the reaction [Acetaldehyde results in decreased expression of BCL2 mRNA] more ... CTD PMID:16814256 acetaldehyde increases expression ISO RGD:1552054 6480464 Acetaldehyde results in increased expression of ADIPOQ mRNA, Acetaldehyde results in increased expression of ADIPOQ protein CTD PMID:17949463 acetaldehyde multiple interactions ISO RGD:1552054 6480464 Acetaldehyde promotes the reaction [ADIPOQ protein results in decreased expression of COL1A1 mRNA], LEP protein affects the reaction [Acetaldehyde results in increased expression of ADIPOQ protein] CTD PMID:17949463 aflatoxin B1 decreases methylation EXP 6480464 Aflatoxin B1 results in decreased methylation of ADIPOQ exon CTD PMID:30157460 AICA ribonucleotide increases expression ISO RGD:1552054 6480464 AICA ribonucleotide results in increased expression of ADIPOQ protein CTD PMID:20980258 AICA ribonucleotide multiple interactions ISO RGD:628748 6480464 AICA ribonucleotide inhibits the reaction [Palmitic Acid results in decreased expression of ADIPOQ mRNA] CTD PMID:25108154 aldehydo-D-glucosamine increases expression ISO RGD:1552054 6480464 Glucosamine results in increased expression of ADIPOQ mRNA CTD PMID:15694357 aldehydo-D-glucosamine increases expression ISO RGD:628748 6480464 Glucosamine results in increased expression of ADIPOQ mRNA CTD PMID:15694357 aldehydo-D-glucose decreases expression ISO RGD:628748 6480464 Glucose results in decreased expression of ADIPOQ protein CTD PMID:21912612 aldehydo-D-glucose increases expression ISO RGD:628748 6480464 Glucose results in increased expression of ADIPOQ protein CTD PMID:29165388 aldehydo-D-glucose multiple interactions EXP 6480464 [Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ mRNA more ... CTD PMID:32407875 aldehydo-D-glucose increases secretion EXP 6480464 Glucose deficiency results in increased secretion of ADIPOQ protein CTD PMID:24802182 aldehydo-D-glucose multiple interactions ISO RGD:628748 6480464 ADIPOQ protein inhibits the reaction [Glucose results in decreased expression of ADIPOR2 protein] more ... CTD PMID:21912612 , PMID:29165388 allopurinol multiple interactions ISO RGD:628748 6480464 Allopurinol promotes the reaction [Acetylcysteine inhibits the reaction [Streptozocin results in decreased expression of ADIPOQ mRNA]], Allopurinol promotes the reaction [Acetylcysteine inhibits the reaction [Streptozocin results in decreased expression of ADIPOQ protein]] CTD PMID:21912612 Aloe emodin multiple interactions EXP 6480464 aloe emodin inhibits the reaction [1-Methyl-3-isobutylxanthine results in decreased expression of ADIPOQ mRNA] CTD PMID:22645054 amlodipine increases expression EXP 6480464 Amlodipine results in increased expression of ADIPOQ, Amlodipine results in increased expression of ADIPOQ protein CTD PMID:18199500 , PMID:19059660 ammonium chloride affects expression ISO RGD:628748 6480464 Ammonium Chloride affects the expression of ADIPOQ mRNA CTD PMID:16483693 amphetamine increases expression ISO RGD:628748 6480464 Amphetamine results in increased expression of ADIPOQ mRNA CTD PMID:30779732 anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions ISO RGD:1552054 6480464 pyrazolanthrone inhibits the reaction [TNF protein results in decreased expression of ADIPOQ mRNA] CTD PMID:18577375 arsane multiple interactions EXP 6480464 T 0070907 promotes the reaction [Arsenic results in decreased expression of ADIPOQ protein] CTD PMID:23108036 arsane affects response to substance EXP 6480464 ADIPOQ gene SNP affects the susceptibility to Arsenic CTD PMID:29723618 arsane decreases expression EXP 6480464 Arsenic results in decreased expression of ADIPOQ protein CTD PMID:23108036 arsane increases expression ISO RGD:1552054 6480464 Arsenic results in increased expression of ADIPOQ mRNA CTD PMID:19654921 arsenic atom increases expression ISO RGD:1552054 6480464 Arsenic results in increased expression of ADIPOQ mRNA CTD PMID:19654921 arsenic atom affects response to substance EXP 6480464 ADIPOQ gene SNP affects the susceptibility to Arsenic CTD PMID:29723618 arsenic atom multiple interactions EXP 6480464 T 0070907 promotes the reaction [Arsenic results in decreased expression of ADIPOQ protein] CTD PMID:23108036 arsenic atom decreases expression EXP 6480464 Arsenic results in decreased expression of ADIPOQ protein CTD PMID:23108036 arsenous acid decreases expression ISO RGD:1552054 6480464 Arsenic Trioxide results in decreased expression of ADIPOQ protein CTD PMID:25859628 atorvastatin calcium decreases expression EXP 6480464 Atorvastatin results in decreased expression of ADIPOQ protein CTD PMID:19651449 atorvastatin calcium increases expression EXP 6480464 Atorvastatin results in increased expression of ADIPOQ protein CTD PMID:19651449 avobenzone multiple interactions EXP 6480464 avobenzone promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of ADIPOQ mRNA] more ... CTD PMID:31016361 , PMID:32407875 benzamides increases expression ISO RGD:1552054 6480464 Benzamides results in increased expression of ADIPOQ mRNA CTD PMID:28242381 benzbromarone multiple interactions ISO RGD:1552054 6480464 2-chloro-5-nitrobenzanilide inhibits the reaction [Benzbromarone results in increased expression of ADIPOQ mRNA] CTD PMID:19048458 benzbromarone increases expression EXP 6480464 Benzbromarone results in increased expression of ADIPOQ protein CTD PMID:19048458 , PMID:21329621 benzbromarone increases expression ISO RGD:1552054 6480464 Benzbromarone results in increased expression of ADIPOQ mRNA CTD PMID:19048458 benzene increases expression ISO RGD:1552054 6480464 Benzene results in increased expression of ADIPOQ mRNA CTD PMID:15120971 , PMID:15122651 benzo[a]pyrene increases expression ISO RGD:1552054 6480464 Benzoapyrene results in increased expression of ADIPOQ mRNA CTD PMID:22228805 benzo[a]pyrene increases methylation EXP 6480464 Benzoapyrene results in increased methylation of ADIPOQ promoter CTD PMID:27901495 benzo[a]pyrene increases expression ISO RGD:628748 6480464 Benzoapyrene results in increased expression of ADIPOQ mRNA CTD PMID:22374506 benzo[b]fluoranthene decreases expression ISO RGD:1552054 6480464 benzobfluoranthene results in decreased expression of ADIPOQ mRNA CTD PMID:26377693 Benzyl parahydroxybenzoate increases expression EXP 6480464 benzylparaben results in increased expression of ADIPOQ mRNA CTD PMID:22956630 Benzyl parahydroxybenzoate increases expression ISO RGD:1552054 6480464 benzylparaben results in increased expression of ADIPOQ mRNA CTD PMID:22956630 berberine multiple interactions ISO RGD:1552054 6480464 Berberine inhibits the reaction [Clozapine results in increased expression of ADIPOQ mRNA], Berberine inhibits the reaction [Risperidone results in increased expression of ADIPOQ mRNA] CTD PMID:20564506 beta-carotene decreases expression ISO RGD:1552054 6480464 beta Carotene results in decreased expression of ADIPOQ mRNA CTD PMID:21569430 beta-D-glucosamine increases expression ISO RGD:1552054 6480464 Glucosamine results in increased expression of ADIPOQ mRNA CTD PMID:15694357 beta-D-glucosamine increases expression ISO RGD:628748 6480464 Glucosamine results in increased expression of ADIPOQ mRNA CTD PMID:15694357 beta-hexachlorocyclohexane affects response to substance EXP 6480464 ADIPOQ gene SNP affects the susceptibility to beta-hexachlorocyclohexane CTD PMID:27883041 beta-hexachlorocyclohexane multiple interactions EXP 6480464 [ADIPOQ gene SNP affects the susceptibility to beta-hexachlorocyclohexane] which affects the expression of ADIPOQ protein CTD PMID:27883041 bezafibrate increases expression EXP 6480464 Bezafibrate results in increased expression of ADIPOQ protein CTD PMID:21411093 bezafibrate multiple interactions ISO RGD:1552054 6480464 Bezafibrate inhibits the reaction [Sodium Glutamate results in decreased expression of ADIPOQ protein] CTD PMID:21549692 bezafibrate increases secretion ISO RGD:1552054 6480464 Bezafibrate results in increased secretion of ADIPOQ protein CTD PMID:17190905 bezafibrate increases expression ISO RGD:1552054 6480464 Bezafibrate results in increased expression of ADIPOQ mRNA, Bezafibrate results in increased expression of ADIPOQ protein CTD PMID:16574099 more ... bis(2-chloroethyl) sulfide increases expression ISO RGD:628748 6480464 Mustard Gas results in increased expression of ADIPOQ mRNA CTD PMID:29129815 bis(2-ethylhexyl) phthalate multiple interactions ISO RGD:1552054 6480464 Diethylhexyl Phthalate promotes the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of ADIPOQ mRNA] CTD PMID:22197818 bis(2-ethylhexyl) phthalate increases expression ISO RGD:628748 6480464 Diethylhexyl Phthalate results in increased expression of ADIPOQ protein CTD PMID:33309551 bis(2-ethylhexyl) phthalate multiple interactions ISO RGD:628748 6480464 Diethylhexyl Phthalate inhibits the reaction [Dietary Fats results in decreased expression of ADIPOQ protein] CTD PMID:33166671 bis(2-ethylhexyl) phthalate multiple interactions EXP 6480464 Diethylhexyl Phthalate promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased secretion of ADIPOQ protein], Diethylhexyl Phthalate promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ protein] CTD PMID:31016361 , PMID:32407875 bis(2-ethylhexyl) phthalate decreases expression ISO RGD:1552054 6480464 Diethylhexyl Phthalate results in decreased expression of ADIPOQ mRNA CTD PMID:22588786 bisphenol A multiple interactions ISO RGD:1552054 6480464 [1-Methyl-3-isobutylxanthine co-treated with bisphenol A co-treated with INS protein] results in increased expression of ADIPOQ protein more ... CTD PMID:22197818 more ... bisphenol A increases secretion ISO RGD:628748 6480464 bisphenol A results in increased secretion of ADIPOQ protein CTD PMID:31697385 bisphenol A multiple interactions EXP 6480464 bisphenol A promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased secretion of ADIPOQ protein] CTD PMID:31016361 bisphenol A decreases expression ISO RGD:628748 6480464 bisphenol A results in decreased expression of ADIPOQ mRNA, bisphenol A results in decreased expression of ADIPOQ protein CTD PMID:24472609 more ... bisphenol A multiple interactions ISO RGD:628748 6480464 [bisphenol A co-treated with Testosterone] results in decreased expression of ADIPOQ mRNA CTD PMID:26496021 bisphenol A increases expression ISO RGD:1552054 6480464 bisphenol A results in increased expression of ADIPOQ mRNA, bisphenol A results in increased expression of ADIPOQ protein CTD PMID:26996129 , PMID:30959087 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of ADIPOQ mRNA CTD PMID:23146750 more ... bisphenol A increases expression ISO RGD:628748 6480464 bisphenol A results in increased expression of ADIPOQ mRNA, bisphenol A results in increased expression of ADIPOQ protein CTD PMID:17010207 , PMID:20219716 bisphenol A decreases expression ISO RGD:1552054 6480464 bisphenol A results in decreased expression of ADIPOQ mRNA CTD PMID:18417718 , PMID:30133442 bisphenol A decreases secretion EXP 6480464 bisphenol A results in decreased secretion of ADIPOQ protein CTD PMID:19079714 Bisphenol A diglycidyl ether increases expression EXP 6480464 2, 2-bis4-glycidyloxyphenylpropane results in increased expression of ADIPOQ mRNA CTD PMID:22763116 Bisphenol A diglycidyl ether increases expression ISO RGD:1552054 6480464 2, 2-bis4-glycidyloxyphenylpropane results in increased expression of ADIPOQ mRNA CTD PMID:22763116 Bisphenol A diglycidyl ether multiple interactions ISO RGD:1552054 6480464 2 more ... CTD PMID:16567512 more ... bongkrekic acid increases expression EXP 6480464 Bongkrekic Acid results in increased expression of ADIPOQ mRNA CTD PMID:25786526 boric acid multiple interactions ISO RGD:1552054 6480464 boric acid inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of ADIPOQ mRNA], boric acid inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of and results in increased secretion of ADIPOQ protein] CTD PMID:28285642 Butylbenzyl phthalate multiple interactions ISO RGD:1552054 6480464 [1-Methyl-3-isobutylxanthine co-treated with butylbenzyl phthalate co-treated with INS protein] results in increased expression of ADIPOQ mRNA more ... CTD PMID:26820058 , PMID:28595985 Butylbenzyl phthalate multiple interactions EXP 6480464 butylbenzyl phthalate promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased secretion of ADIPOQ protein], butylbenzyl phthalate promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ protein] CTD PMID:31016361 , PMID:32407875 Butylparaben increases expression EXP 6480464 butylparaben results in increased expression of ADIPOQ mRNA CTD PMID:22956630 Butylparaben multiple interactions EXP 6480464 butylparaben promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased secretion of ADIPOQ protein] CTD PMID:31016361 Butylparaben increases expression ISO RGD:1552054 6480464 butylparaben results in increased expression of ADIPOQ mRNA CTD PMID:22956630 Butylparaben multiple interactions ISO RGD:1552054 6480464 2 more ... CTD PMID:22956630 cadmium dichloride decreases expression ISO RGD:1552054 6480464 Cadmium Chloride results in decreased expression of ADIPOQ mRNA CTD PMID:19666079 cadmium dichloride multiple interactions ISO RGD:1552054 6480464 [MT1 gene mutant form results in increased susceptibility to Cadmium Chloride] which results in decreased expression of ADIPOQ mRNA, [MT2 gene mutant form results in increased susceptibility to Cadmium Chloride] which results in decreased expression of ADIPOQ mRNA CTD PMID:23921151 calcitriol multiple interactions EXP 6480464 [Calcitriol co-treated with Cortisone] results in decreased expression of ADIPOQ mRNA CTD PMID:19918113 candesartan multiple interactions EXP 6480464 [candesartan co-treated with Fenofibrate] results in increased expression of ADIPOQ protein more ... CTD PMID:16443859 , PMID:17483542 candesartan increases expression EXP 6480464 candesartan results in increased expression of ADIPOQ, candesartan results in increased expression of ADIPOQ protein CTD PMID:16443859 more ... candesartan decreases expression EXP 6480464 candesartan results in decreased expression of ADIPOQ CTD PMID:17483542 capsaicin increases secretion ISO RGD:1552054 6480464 Capsaicin results in increased secretion of ADIPOQ protein CTD PMID:17719033 capsaicin increases expression ISO RGD:1552054 6480464 Capsaicin results in increased expression of ADIPOQ mRNA, Capsaicin results in increased expression of ADIPOQ protein CTD PMID:17295509 more ... capsazepine multiple interactions ISO RGD:1552054 6480464 capsazepine inhibits the reaction [Olanzapine results in decreased expression of ADIPOQ protein] CTD PMID:32652086 carbon monoxide multiple interactions ISO RGD:628748 6480464 2-4-morpholinyl-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[Carbon Monoxide results in increased expression of ADIPOQ protein] which results in increased phosphorylation of AKT1 protein] more ... CTD PMID:19356108 carbon monoxide increases expression ISO RGD:628748 6480464 [Carbon Monoxide results in increased expression of ADIPOQ protein] which results in increased expression of PECAM1 protein, Carbon Monoxide results in increased expression of ADIPOQ protein CTD PMID:19356108 carbon nanotube decreases expression ISO RGD:1552054 6480464 Nanotubes, Carbon analog results in decreased expression of ADIPOQ mRNA CTD PMID:25620056 carvacrol multiple interactions ISO RGD:628748 6480464 carvacrol inhibits the reaction [Poloxamer results in decreased secretion of ADIPOQ protein], carvacrol promotes the reaction [Simvastatin inhibits the reaction [Poloxamer results in decreased secretion of ADIPOQ protein]] CTD PMID:29071762 carvedilol decreases expression EXP 6480464 carvedilol results in decreased expression of ADIPOQ protein CTD PMID:19367012 cilazapril monohydrate increases expression EXP 6480464 Cilazapril results in increased expression of ADIPOQ protein CTD PMID:19789415 cimetidine multiple interactions EXP 6480464 Cimetidine promotes the reaction [Metformin results in decreased expression of ADIPOQ mRNA] CTD PMID:20956498 clozapine decreases expression EXP 6480464 Clozapine results in decreased expression of ADIPOQ protein CTD PMID:18162013 clozapine increases expression ISO RGD:628748 6480464 Clozapine results in increased expression of ADIPOQ protein CTD PMID:17933447 clozapine increases expression ISO RGD:1552054 6480464 Clozapine results in increased expression of ADIPOQ mRNA CTD PMID:20564506 clozapine multiple interactions ISO RGD:1552054 6480464 Berberine inhibits the reaction [Clozapine results in increased expression of ADIPOQ mRNA] CTD PMID:20564506 cobalt dichloride increases secretion ISO RGD:1552054 6480464 cobaltous chloride results in increased secretion of ADIPOQ protein CTD PMID:22019852 cobalt dichloride decreases expression ISO RGD:1552054 6480464 cobaltous chloride results in decreased expression of ADIPOQ mRNA CTD PMID:20594416 conjugated linoleic acid multiple interactions ISO RGD:628748 6480464 [picolinic acid co-treated with Linoleic Acids, Conjugated] results in increased expression of ADIPOQ protein CTD PMID:17199723 conjugated linoleic acid decreases expression ISO RGD:1552054 6480464 Linoleic Acids, Conjugated results in decreased expression of ADIPOQ protein CTD PMID:17322064 copper atom decreases expression ISO RGD:628748 6480464 Copper results in decreased expression of ADIPOQ mRNA CTD PMID:30556269 copper(0) decreases expression ISO RGD:628748 6480464 Copper results in decreased expression of ADIPOQ mRNA CTD PMID:30556269 corticosterone multiple interactions EXP 6480464 [Corticosterone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of and results in increased secretion of ADIPOQ protein CTD PMID:29782964 cortisone multiple interactions EXP 6480464 [Calcitriol co-treated with Cortisone] results in decreased expression of ADIPOQ mRNA CTD PMID:19918113 cucurbitacin B decreases expression ISO RGD:1552054 6480464 cucurbitacin B results in decreased expression of ADIPOQ mRNA CTD PMID:24316209 cucurbitacin I multiple interactions ISO RGD:628748 6480464 cucurbitacin I inhibits the reaction [ADIPOQ protein results in increased expression of HMOX1 mRNA] CTD PMID:20052772 curcumin increases expression ISO RGD:1552054 6480464 Curcumin results in increased expression of ADIPOQ mRNA, Curcumin results in increased expression of ADIPOQ protein CTD PMID:18403477 curcumin multiple interactions ISO RGD:1552054 6480464 Curcumin inhibits the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of ADIPOQ mRNA], Curcumin inhibits the reaction [butylbenzyl phthalate promotes the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of ADIPOQ mRNA]] CTD PMID:28595985 curcumin affects expression ISO RGD:1552054 6480464 Curcumin affects the expression of ADIPOQ mRNA CTD PMID:27208389 curcumin multiple interactions ISO RGD:628748 6480464 Curcumin inhibits the reaction [Fructose results in decreased expression of ADIPOQ protein] CTD PMID:26713546 cyclosporin A decreases secretion ISO RGD:628748 6480464 Cyclosporine results in decreased secretion of ADIPOQ protein CTD PMID:28886988 cyproterone acetate multiple interactions EXP 6480464 Cyproterone Acetate inhibits the reaction [[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of and results in increased secretion of ADIPOQ protein] CTD PMID:29782964 cytarabine multiple interactions ISO RGD:1552054 6480464 [2, 2-bis4-glycidyloxyphenylpropane co-treated with Cytarabine] results in decreased expression of ADIPOQ mRNA CTD PMID:23264188 D-glucose multiple interactions EXP 6480464 [Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ mRNA more ... CTD PMID:32407875 D-glucose increases expression ISO RGD:628748 6480464 Glucose results in increased expression of ADIPOQ protein CTD PMID:29165388 D-glucose increases secretion EXP 6480464 Glucose deficiency results in increased secretion of ADIPOQ protein CTD PMID:24802182 D-glucose decreases expression ISO RGD:628748 6480464 Glucose results in decreased expression of ADIPOQ protein CTD PMID:21912612 D-glucose multiple interactions ISO RGD:628748 6480464 ADIPOQ protein inhibits the reaction [Glucose results in decreased expression of ADIPOR2 protein] more ... CTD PMID:21912612 , PMID:29165388 DDE increases expression ISO RGD:1552054 6480464 Dichlorodiphenyl Dichloroethylene results in increased expression of ADIPOQ mRNA CTD PMID:21044676 DDE multiple interactions ISO RGD:1552054 6480464 [Dietary Fats co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of ADIPOQ protein CTD PMID:25541407 DDE increases secretion ISO RGD:1552054 6480464 Dichlorodiphenyl Dichloroethylene results in increased secretion of ADIPOQ protein CTD PMID:21044676 deoxycholic acid decreases expression ISO RGD:1552054 6480464 Deoxycholic Acid results in decreased expression of ADIPOQ mRNA CTD PMID:23911798 Deoxycorticosterone acetate decreases expression ISO RGD:628748 6480464 Desoxycorticosterone Acetate results in decreased expression of ADIPOQ protein CTD PMID:23089228 Deoxycorticosterone acetate multiple interactions ISO RGD:628748 6480464 chromium mesoporphyrin inhibits the reaction [heme arginate inhibits the reaction [Desoxycorticosterone Acetate results in decreased expression of ADIPOQ protein]] more ... CTD PMID:23089228 dexamethasone multiple interactions ISO RGD:1552054 6480464 2 more ... CTD PMID:16054899 more ... dexamethasone increases expression ISO RGD:1552054 6480464 Dexamethasone results in increased expression of ADIPOQ mRNA CTD PMID:22956630 , PMID:25851902 dexamethasone increases expression EXP 6480464 Dexamethasone results in increased expression of ADIPOQ mRNA CTD PMID:19853017 more ... dexamethasone increases expression ISO RGD:628748 6480464 Dexamethasone results in increased expression of ADIPOQ mRNA CTD PMID:23166830 dexamethasone multiple interactions EXP 6480464 17 alpha-Hydroxyprogesterone Caproate inhibits the reaction [[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of and results in increased secretion of ADIPOQ protein] more ... CTD PMID:19186324 more ... dexamethasone phosphate multiple interactions EXP 6480464 [dexamethasone 21-phosphate co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of and results in increased secretion of ADIPOQ protein CTD PMID:29782964 diarsenic trioxide decreases expression ISO RGD:1552054 6480464 Arsenic Trioxide results in decreased expression of ADIPOQ protein CTD PMID:25859628 dibenziodolium multiple interactions ISO RGD:628748 6480464 diphenyleneiodonium inhibits the reaction [Palmitates results in decreased expression of ADIPOQ mRNA], diphenyleneiodonium inhibits the reaction [Palmitates results in decreased expression of ADIPOQ protein] CTD PMID:17471172 dibenziodolium multiple interactions EXP 6480464 diphenyleneiodonium inhibits the reaction [Indinavir results in decreased expression of ADIPOQ protein] more ... CTD PMID:17668557 dicamba multiple interactions EXP 6480464 Dicamba inhibits the reaction [[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of and results in increased secretion of ADIPOQ protein] CTD PMID:29782964 diethyl sulfate multiple interactions EXP 6480464 diethyl sulfate inhibits the reaction [[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of and results in increased secretion of ADIPOQ protein] CTD PMID:29782964 diethylstilbestrol increases expression ISO RGD:628748 6480464 Diethylstilbestrol results in increased expression of ADIPOQ mRNA CTD PMID:17010207 dioxygen decreases expression ISO RGD:1552054 6480464 Oxygen deficiency results in decreased expression of ADIPOQ mRNA CTD PMID:20594416 dioxygen increases expression ISO RGD:1552054 6480464 Oxygen deficiency results in increased expression of ADIPOQ mRNA CTD PMID:23539316 disodium cromoglycate increases expression ISO RGD:1552054 6480464 Cromolyn Sodium results in increased expression of ADIPOQ protein CTD PMID:23784744 disodium selenite decreases expression EXP 6480464 Sodium Selenite results in decreased expression of ADIPOQ mRNA CTD PMID:18175754 diuron decreases expression ISO RGD:628748 6480464 Diuron results in decreased expression of ADIPOQ mRNA CTD PMID:25152437 dorsomorphin multiple interactions ISO RGD:1552054 6480464 [dorsomorphin inhibits the reaction [ADIPOQ protein results in increased expression of BCL2L1 protein]] which results in increased activity of CASP3 protein more ... CTD PMID:20709802 , PMID:20980258 dorsomorphin multiple interactions EXP 6480464 dorsomorphin inhibits the reaction [ADIPOQ protein modified form results in increased activity of PPARA protein] CTD PMID:29991592 doxorubicin multiple interactions ISO RGD:1552054 6480464 [[MT1 protein co-treated with MT2 protein] affects the susceptibility to Doxorubicin] which affects the expression of ADIPOQ mRNA CTD PMID:21040762 efavirenz decreases expression EXP 6480464 efavirenz results in decreased expression of ADIPOQ mRNA CTD PMID:21619898 efavirenz decreases secretion EXP 6480464 efavirenz results in decreased secretion of ADIPOQ protein CTD PMID:21619898 enalapril increases expression ISO RGD:1552054 6480464 Enalapril results in increased expression of ADIPOQ protein CTD PMID:25037058 equilin multiple interactions EXP 6480464 Equilin inhibits the reaction [[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of and results in increased secretion of ADIPOQ protein] CTD PMID:29782964 ethanol decreases expression ISO RGD:1552054 6480464 Ethanol results in decreased expression of ADIPOQ more ... CTD PMID:18755807 more ... ethanol decreases expression ISO RGD:628748 6480464 [Ethanol results in decreased expression of PPARG protein] which results in decreased expression of ADIPOQ protein more ... CTD PMID:24412557 , PMID:26115886 ethanol decreases response to substance EXP 6480464 ADIPOQ protein results in decreased susceptibility to Ethanol CTD PMID:24582693 ethanol multiple interactions EXP 6480464 ADIPOQ protein inhibits the reaction [Ethanol results in decreased expression of ATG5 mRNA] more ... CTD PMID:24582693 ethanol decreases secretion ISO RGD:628748 6480464 Ethanol results in decreased secretion of ADIPOQ protein CTD PMID:24412557 , PMID:32171850 ethanol multiple interactions ISO RGD:628748 6480464 ADIPOQ protein inhibits the reaction [Ethanol promotes the reaction [Lipopolysaccharides results in increased expression of CXCL10 mRNA]] more ... CTD PMID:20052772 more ... ethanol multiple interactions ISO RGD:1552054 6480464 [Ethanol co-treated with Resveratrol] results in increased expression of ADIPOQ protein more ... CTD PMID:18755807 more ... ethylparaben increases expression ISO RGD:1552054 6480464 ethyl-p-hydroxybenzoate results in increased expression of ADIPOQ mRNA CTD PMID:22956630 fenofibrate multiple interactions EXP 6480464 [candesartan co-treated with Fenofibrate] results in increased expression of ADIPOQ protein more ... CTD PMID:16443859 , PMID:24735863 fenofibrate increases expression EXP 6480464 Fenofibrate results in increased expression of ADIPOQ protein CTD PMID:16443859 flavonoids decreases expression ISO RGD:628748 6480464 Flavonoids results in decreased expression of ADIPOQ mRNA CTD PMID:18035473 fructose multiple interactions ISO RGD:628748 6480464 [Particulate Matter co-treated with Ozone] promotes the reaction [Fructose results in decreased expression of ADIPOQ mRNA] more ... CTD PMID:17098227 more ... fructose decreases secretion ISO RGD:628748 6480464 Fructose results in decreased secretion of ADIPOQ protein CTD PMID:25679220 fructose increases secretion ISO RGD:1552054 6480464 Fructose results in increased secretion of ADIPOQ protein CTD PMID:28257781 fructose decreases expression ISO RGD:628748 6480464 Fructose results in decreased expression of ADIPOQ mRNA, Fructose results in decreased expression of ADIPOQ protein CTD PMID:17098227 more ... fructose increases expression ISO RGD:628748 6480464 Fructose results in increased expression of ADIPOQ mRNA, Fructose results in increased expression of ADIPOQ protein CTD PMID:21122807 , PMID:23016136 fructose increases secretion ISO RGD:628748 6480464 Fructose results in increased secretion of ADIPOQ protein CTD PMID:19165636 furan increases expression ISO RGD:628748 6480464 furan results in increased expression of ADIPOQ mRNA CTD PMID:27387713 gemcitabine increases expression EXP 6480464 gemcitabine results in increased expression of ADIPOQ protein CTD PMID:20531411 geraniol multiple interactions ISO RGD:628748 6480464 geraniol inhibits the reaction [Fructose results in decreased secretion of ADIPOQ protein], geraniol promotes the reaction [Streptozocin results in decreased expression of ADIPOQ protein] CTD PMID:25679220 , PMID:28178614 gingerol multiple interactions ISO RGD:1552054 6480464 gingerol inhibits the reaction [TNF protein results in decreased expression of ADIPOQ mRNA], gingerol inhibits the reaction [TNF protein results in decreased expression of and results in decreased secretion of ADIPOQ protein] CTD PMID:18577375 , PMID:21851089 ginsenoside Re increases expression ISO RGD:1552054 6480464 ginsenoside Re results in increased expression of ADIPOQ mRNA CTD PMID:23545455 ginsenoside Re multiple interactions ISO RGD:1552054 6480464 ginsenoside Re results in increased expression of and results in increased secretion of ADIPOQ protein CTD PMID:23545455 glucagon multiple interactions ISO RGD:1552054 6480464 Glucagon analog inhibits the reaction [[Dietary Fats co-treated with Streptozocin] results in decreased expression of and results in decreased secretion of ADIPOQ protein], Glucagon analog inhibits the reaction [LEPR gene mutant form results in decreased expression of and results in decreased secretion of ADIPOQ protein] CTD PMID:29988851 glucose multiple interactions ISO RGD:628748 6480464 ADIPOQ protein inhibits the reaction [Glucose results in decreased expression of ADIPOR2 protein] more ... CTD PMID:21912612 , PMID:29165388 glucose multiple interactions EXP 6480464 [Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ mRNA more ... CTD PMID:32407875 glucose increases expression ISO RGD:628748 6480464 Glucose results in increased expression of ADIPOQ protein CTD PMID:29165388 glucose increases secretion EXP 6480464 Glucose deficiency results in increased secretion of ADIPOQ protein CTD PMID:24802182 glucose decreases expression ISO RGD:628748 6480464 Glucose results in decreased expression of ADIPOQ protein CTD PMID:21912612 glycine increases expression ISO RGD:1552054 6480464 Glycine results in increased expression of ADIPOQ protein CTD PMID:18930730 graphite increases expression ISO RGD:1552054 6480464 Graphite results in increased expression of ADIPOQ mRNA CTD PMID:27440207 GW 6471 multiple interactions ISO RGD:1552054 6480464 GW 6471 inhibits the reaction [[GW 7647 co-treated with PPARA protein] results in increased expression of ADIPOQ mRNA] more ... CTD PMID:20709802 , PMID:21324916 GW 6471 decreases expression ISO RGD:1552054 6480464 GW 6471 results in decreased expression of ADIPOQ mRNA CTD PMID:21324916 GW 7647 multiple interactions ISO RGD:1552054 6480464 GW 6471 inhibits the reaction [[GW 7647 co-treated with PPARA protein] results in increased expression of ADIPOQ mRNA] CTD PMID:21324916 hemin increases secretion ISO RGD:628748 6480464 Hemin results in increased secretion of ADIPOQ protein CTD PMID:20016031 hesperetin decreases expression EXP 6480464 hesperetin results in decreased expression of ADIPOQ mRNA CTD PMID:25345581 hexadecanoic acid decreases expression ISO RGD:628748 6480464 Palmitic Acid results in decreased expression of ADIPOQ mRNA CTD PMID:25108154 hexadecanoic acid multiple interactions EXP 6480464 3-4-chlorophenyl-N-methyl-N'-4-chlorophenylsulfonyl-4-phenyl-4 more ... CTD PMID:31454063 hexadecanoic acid multiple interactions ISO RGD:628748 6480464 AICA ribonucleotide inhibits the reaction [Palmitic Acid results in decreased expression of ADIPOQ mRNA] more ... CTD PMID:25108154 hispidulin multiple interactions ISO RGD:1552054 6480464 hispidulin inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein co-treated with Indomethacin] results in increased expression of ADIPOQ mRNA], hispidulin inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein co-treated with Indomethacin] results in increased expression of ADIPOQ protein] CTD PMID:30055130 hydrochlorothiazide decreases expression ISO RGD:1552054 6480464 Hydrochlorothiazide results in decreased expression of ADIPOQ mRNA CTD PMID:19730415 hydrogen peroxide decreases secretion ISO RGD:1552054 6480464 Hydrogen Peroxide results in decreased secretion of ADIPOQ protein CTD PMID:18303122 hydroxytyrosol decreases expression ISO RGD:1552054 6480464 3, 4-dihydroxyphenylethanol results in decreased expression of ADIPOQ mRNA CTD PMID:21569430 Indeno[1,2,3-cd]pyrene decreases expression ISO RGD:1552054 6480464 indeno1 more ... CTD PMID:26377693 indinavir decreases expression EXP 6480464 Indinavir results in decreased expression of ADIPOQ protein CTD PMID:17668557 indinavir decreases expression ISO RGD:1552054 6480464 Indinavir results in decreased expression of ADIPOQ mRNA, Indinavir results in decreased expression of ADIPOQ protein CTD PMID:15865214 indinavir multiple interactions EXP 6480464 diphenyleneiodonium inhibits the reaction [Indinavir results in decreased expression of ADIPOQ protein], Indinavir inhibits the reaction [ADIPOQ protein modified form results in increased uptake of Deoxyglucose] CTD PMID:17668557 , PMID:29991592 indometacin multiple interactions EXP 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of ADIPOQ mRNA more ... CTD PMID:23086663 , PMID:28628672 indometacin multiple interactions ISO RGD:1552054 6480464 [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein co-treated with Indomethacin] results in increased expression of ADIPOQ mRNA more ... CTD PMID:30055130 iron dextran multiple interactions ISO RGD:1552054 6480464 [ADIPOQ protein results in increased expression of BCL2L1 protein] inhibits the reaction [Iron-Dextran Complex results in increased activity of CASP3 protein] more ... CTD PMID:20709802 isoflavones decreases expression ISO RGD:628748 6480464 Isoflavones results in decreased expression of ADIPOQ protein CTD PMID:22155228 isoflavones increases expression ISO RGD:628748 6480464 Isoflavones results in increased expression of ADIPOQ protein CTD PMID:22155228 lamivudine multiple interactions ISO RGD:1552054 6480464 [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in decreased expression of ADIPOQ mRNA CTD PMID:16931933 lead diacetate decreases expression ISO RGD:628748 6480464 lead acetate results in decreased expression of ADIPOQ mRNA CTD PMID:11578147 levonorgestrel multiple interactions EXP 6480464 Norgestrel inhibits the reaction [[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of and results in increased secretion of ADIPOQ protein] CTD PMID:29782964 linoleic acid decreases expression ISO RGD:1552054 6480464 Linoleic Acid results in decreased expression of ADIPOQ mRNA CTD PMID:17374693 lipoic acid multiple interactions ISO RGD:628748 6480464 Thioctic Acid inhibits the reaction [Dietary Fats results in decreased expression of ADIPOQ mRNA], Thioctic Acid inhibits the reaction [Dietary Fats results in decreased expression of ADIPOQ protein] CTD PMID:22664981 lipoic acid increases expression ISO RGD:628748 6480464 Thioctic Acid results in increased expression of ADIPOQ mRNA, Thioctic Acid results in increased expression of ADIPOQ protein CTD PMID:22664981 lipopolysaccharide increases expression ISO RGD:1552054 6480464 Lipopolysaccharides results in increased expression of ADIPOQ mRNA CTD PMID:17641834 lipopolysaccharide multiple interactions ISO RGD:628748 6480464 ADIPOQ protein inhibits the reaction [Ethanol promotes the reaction [Lipopolysaccharides results in increased expression of CXCL10 mRNA]] more ... CTD PMID:20052772 , PMID:20861358 lipopolysaccharide decreases response to substance ISO RGD:1552054 6480464 ADIPOQ results in decreased susceptibility to Lipopolysaccharides CTD PMID:22156343 lipopolysaccharide multiple interactions EXP 6480464 ADIPOQ inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 protein] CTD PMID:22156343 lipopolysaccharide multiple interactions ISO RGD:1552054 6480464 ADIPOQ gene mutant form promotes the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA] more ... CTD PMID:17641834 more ... lipopolysaccharide increases secretion ISO RGD:1552054 6480464 Lipopolysaccharides results in increased secretion of ADIPOQ protein CTD PMID:17641834 liraglutide multiple interactions ISO RGD:1552054 6480464 Liraglutide inhibits the reaction [IL1B protein results in decreased secretion of ADIPOQ protein] CTD PMID:32898504 lopinavir decreases expression EXP 6480464 Lopinavir results in decreased expression of ADIPOQ protein CTD PMID:17668557 lopinavir multiple interactions EXP 6480464 diphenyleneiodonium inhibits the reaction [Lopinavir results in decreased expression of ADIPOQ protein] CTD PMID:17668557 losartan increases expression ISO RGD:1552054 6480464 Losartan results in increased expression of ADIPOQ mRNA CTD PMID:19730415 lovastatin affects expression ISO RGD:1552054 6480464 Lovastatin affects the expression of ADIPOQ mRNA CTD PMID:27208389 lovastatin multiple interactions ISO RGD:1552054 6480464 [Dietary Fats co-treated with Lovastatin] affects the expression of ADIPOQ mRNA CTD PMID:29852127 LY294002 multiple interactions ISO RGD:628748 6480464 2-4-morpholinyl-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[Carbon Monoxide results in increased expression of ADIPOQ protein] which results in increased phosphorylation of AKT1 protein], 2-4-morpholinyl-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[Carbon Monoxide results in increased expression of ADIPOQ protein] which results in increased phosphorylation of NOS3 protein] CTD PMID:19356108 manganese(II) chloride increases expression ISO RGD:628748 6480464 manganese chloride results in increased expression of ADIPOQ mRNA CTD PMID:28801915 melatonin decreases expression EXP 6480464 Melatonin results in decreased expression of ADIPOQ mRNA CTD PMID:20738756 Melengestrol acetate multiple interactions EXP 6480464 [Melengestrol Acetate co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of and results in increased secretion of ADIPOQ protein, Melengestrol Acetate inhibits the reaction [[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of and results in increased secretion of ADIPOQ protein] CTD PMID:29782964 mercury dichloride increases expression ISO RGD:628748 6480464 Mercuric Chloride results in increased expression of ADIPOQ mRNA CTD PMID:30807803 metformin decreases expression EXP 6480464 Metformin results in decreased expression of ADIPOQ mRNA CTD PMID:20956498 metformin increases expression ISO RGD:628748 6480464 Metformin results in increased expression of ADIPOQ protein CTD PMID:30256492 metformin multiple interactions ISO RGD:1552054 6480464 Metformin inhibits the reaction [Olanzapine results in decreased expression of ADIPOQ protein] CTD PMID:32652086 metformin multiple interactions ISO RGD:628748 6480464 Metformin inhibits the reaction [Fructose results in decreased expression of ADIPOQ protein], Metformin inhibits the reaction [Palmitic Acid results in decreased expression of ADIPOQ mRNA] CTD PMID:25108154 metformin multiple interactions EXP 6480464 Cimetidine promotes the reaction [Metformin results in decreased expression of ADIPOQ mRNA] CTD PMID:20956498 methamphetamine decreases expression ISO RGD:1552054 6480464 Methamphetamine results in decreased expression of ADIPOQ mRNA CTD PMID:26307267 mifepristone multiple interactions ISO RGD:1552054 6480464 Mifepristone inhibits the reaction [butylparaben results in increased expression of ADIPOQ mRNA] CTD PMID:22956630 mifepristone multiple interactions EXP 6480464 Mifepristone inhibits the reaction [[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of and results in increased secretion of ADIPOQ protein] CTD PMID:29782964 mono(2-ethylhexyl) phthalate increases expression ISO RGD:1552054 6480464 mono-2-ethylhexylphthalate results in increased expression of ADIPOQ protein CTD PMID:27384973 monocrotophos decreases expression ISO RGD:628748 6480464 Monocrotophos results in decreased expression of ADIPOQ protein CTD PMID:32267039 monosodium L-glutamate multiple interactions ISO RGD:1552054 6480464 [Sodium Glutamate co-treated with Pioglitazone] results in increased expression of ADIPOQ protein more ... CTD PMID:21549692 more ... monosodium L-glutamate decreases expression ISO RGD:1552054 6480464 Sodium Glutamate results in decreased expression of ADIPOQ protein CTD PMID:21549692 , PMID:32103741 morin multiple interactions ISO RGD:628748 6480464 morin analog inhibits the reaction [[Streptozocin co-treated with Dietary Fats] results in decreased expression of ADIPOQ protein] CTD PMID:24854284 N-acetyl-L-cysteine multiple interactions ISO RGD:628748 6480464 Acetylcysteine inhibits the reaction [Palmitates results in decreased expression of ADIPOQ mRNA] more ... CTD PMID:17471172 , PMID:21912612 naproxen increases expression ISO RGD:1552054 6480464 Naproxen results in increased expression of ADIPOQ protein CTD PMID:23784744 naringin multiple interactions ISO RGD:1552054 6480464 naringin inhibits the reaction [Dietary Fats results in decreased expression of ADIPOQ protein] CTD PMID:22198281 nelfinavir multiple interactions EXP 6480464 diphenyleneiodonium inhibits the reaction [Nelfinavir results in decreased expression of ADIPOQ protein] CTD PMID:17668557 nelfinavir decreases expression EXP 6480464 Nelfinavir results in decreased expression of ADIPOQ protein CTD PMID:17668557 nelfinavir decreases expression ISO RGD:1552054 6480464 Nelfinavir results in decreased expression of ADIPOQ mRNA, Nelfinavir results in decreased expression of ADIPOQ protein CTD PMID:15865214 nelfinavir multiple interactions ISO RGD:1552054 6480464 rosiglitazone inhibits the reaction [Nelfinavir results in decreased secretion of ADIPOQ protein] CTD PMID:15865214 nevirapine increases expression EXP 6480464 Nevirapine results in increased expression of ADIPOQ mRNA CTD PMID:21619898 nevirapine increases secretion EXP 6480464 Nevirapine results in increased secretion of ADIPOQ protein CTD PMID:21619898 nicotinamide increases secretion ISO RGD:1552054 6480464 Niacinamide results in increased secretion of ADIPOQ protein CTD PMID:17452443 nicotinamide multiple interactions ISO RGD:628748 6480464 [Streptozocin co-treated with Niacinamide] results in decreased expression of ADIPOQ protein, resveratrol inhibits the reaction [[Streptozocin co-treated with Niacinamide] results in decreased expression of ADIPOQ protein] CTD PMID:21439372 nicotinic acid increases expression ISO RGD:1552054 6480464 Niacin results in increased expression of ADIPOQ mRNA, Niacin results in increased expression of ADIPOQ protein CTD PMID:19141678 , PMID:21236357 nicotinic acid multiple interactions ISO RGD:1552054 6480464 HCAR2 protein promotes the reaction [Niacin results in increased expression of ADIPOQ protein] CTD PMID:19141678 nicotinic acid multiple interactions EXP 6480464 Niacin promotes the reaction [ADIPOQ protein binds to ADIPOQ protein] CTD PMID:17996241 , PMID:18249215 nicotinic acid increases expression EXP 6480464 Niacin results in increased expression of ADIPOQ mRNA, Niacin results in increased expression of ADIPOQ protein CTD PMID:16887123 more ... nicotinic acid increases expression ISO RGD:628748 6480464 Niacin results in increased expression of ADIPOQ protein CTD PMID:19141678 Nonylphenol affects expression ISO RGD:1552054 6480464 nonylphenol affects the expression of ADIPOQ mRNA CTD PMID:18417718 Nonylphenol increases expression ISO RGD:628748 6480464 nonylphenol results in increased expression of ADIPOQ mRNA CTD PMID:17010207 norethisterone multiple interactions EXP 6480464 Norethindrone inhibits the reaction [[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of and results in increased secretion of ADIPOQ protein] CTD PMID:29782964 norgestrel multiple interactions EXP 6480464 Norgestrel inhibits the reaction [[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of and results in increased secretion of ADIPOQ protein] CTD PMID:29782964 nuarimol affects binding EXP 6480464 nuarimol binds to ADIPOQ protein CTD PMID:32278787 octadecanoic acid decreases expression ISO RGD:1552054 6480464 stearic acid results in decreased expression of ADIPOQ mRNA CTD PMID:17374693 octadecanoic acid multiple interactions ISO RGD:1552054 6480464 resveratrol inhibits the reaction [stearic acid results in decreased expression of ADIPOQ mRNA] CTD PMID:17374693 olanzapine increases expression ISO RGD:1552054 6480464 olanzapine results in increased expression of ADIPOQ mRNA CTD PMID:17651982 olanzapine decreases expression ISO RGD:1552054 6480464 Olanzapine results in decreased expression of ADIPOQ protein CTD PMID:32652086 olanzapine multiple interactions ISO RGD:1552054 6480464 capsazepine inhibits the reaction [Olanzapine results in decreased expression of ADIPOQ protein] more ... CTD PMID:32652086 oleic acid decreases expression ISO RGD:628748 6480464 Oleic Acid results in decreased expression of ADIPOQ mRNA CTD PMID:23395669 oleic acid multiple interactions ISO RGD:628748 6480464 sophocarpine inhibits the reaction [Oleic Acid results in decreased expression of ADIPOQ mRNA] CTD PMID:23395669 oleuropein multiple interactions ISO RGD:628748 6480464 oleuropein inhibits the reaction [Cholesterol, Dietary results in decreased secretion of ADIPOQ protein] CTD PMID:27019295 orientin multiple interactions ISO RGD:1552054 6480464 orientin inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of ADIPOQ protein] CTD PMID:32044341 orlistat multiple interactions ISO RGD:628748 6480464 orlistat inhibits the reaction [Dietary Fats results in decreased expression of ADIPOQ protein] CTD PMID:25087745 oxybenzone multiple interactions EXP 6480464 oxybenzone promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ mRNA], oxybenzone promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ protein] CTD PMID:32407875 ozone decreases expression ISO RGD:1552054 6480464 Ozone results in decreased expression of ADIPOQ mRNA CTD PMID:12763052 ozone multiple interactions ISO RGD:628748 6480464 [Ozone co-treated with Particulate Matter] results in decreased expression of ADIPOQ mRNA more ... CTD PMID:23968387 ozone increases expression ISO RGD:628748 6480464 Ozone results in increased expression of ADIPOQ CTD PMID:24103449 ozone affects response to substance ISO RGD:1552054 6480464 ADIPOQ protein affects the susceptibility to Ozone CTD PMID:23755285 ozone multiple interactions ISO RGD:1552054 6480464 [ADIPOQ protein binds to CDH13 protein] inhibits the reaction [Ozone results in increased expression of IL17A mRNA] more ... CTD PMID:23755285 paraquat multiple interactions ISO RGD:1552054 6480464 ADIPOQ protein inhibits the reaction [Paraquat results in increased expression of ACTA2 mRNA] more ... CTD PMID:25945502 paraquat multiple interactions EXP 6480464 ADIPOQ protein inhibits the reaction [Paraquat results in increased expression of COL3A1 mRNA] more ... CTD PMID:25945502 paricalcitol increases expression ISO RGD:1552054 6480464 paricalcitol results in increased expression of ADIPOQ protein CTD PMID:25037058 PCB138 multiple interactions ISO RGD:1552054 6480464 [2 more ... CTD PMID:25510870 PCB138 affects expression EXP 6480464 2 more ... CTD PMID:21703328 pencycuron affects binding EXP 6480464 pencycuron binds to ADIPOQ protein CTD PMID:32278787 perfluorooctanoic acid decreases expression EXP 6480464 perfluorooctanoic acid results in decreased expression of ADIPOQ mRNA CTD PMID:23146750 phenobarbital decreases expression ISO RGD:1552054 6480464 Phenobarbital results in decreased expression of ADIPOQ mRNA CTD PMID:19270015 Phenylamil multiple interactions ISO RGD:1552054 6480464 PPARG protein promotes the reaction [phenylamil results in increased expression of ADIPOQ mRNA] CTD PMID:20519739 Phenylamil increases expression ISO RGD:1552054 6480464 phenylamil results in increased expression of ADIPOQ mRNA CTD PMID:20519739 phosphatidylcholine decreases expression ISO RGD:1552054 6480464 Phosphatidylcholines results in decreased expression of ADIPOQ mRNA CTD PMID:23911798 picolinic acid multiple interactions ISO RGD:628748 6480464 [picolinic acid co-treated with Linoleic Acids, Conjugated] results in increased expression of ADIPOQ protein CTD PMID:17199723 pioglitazone multiple interactions ISO RGD:1552054 6480464 2-chloro-5-nitrobenzanilide inhibits the reaction [Pioglitazone results in increased expression of ADIPOQ mRNA] more ... CTD PMID:12927809 more ... pioglitazone decreases expression ISO RGD:1552054 6480464 Pioglitazone results in decreased expression of ADIPOQ protein CTD PMID:27918843 pioglitazone increases expression EXP 6480464 Pioglitazone results in increased expression of ADIPOQ mRNA CTD PMID:18815186 pioglitazone multiple interactions EXP 6480464 2-chloro-5-nitrobenzanilide inhibits the reaction [Pioglitazone promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased secretion of ADIPOQ protein]] more ... CTD PMID:31016361 , PMID:32407875 pioglitazone multiple interactions ISO RGD:628748 6480464 Pioglitazone inhibits the reaction [Dietary Fats results in decreased expression of ADIPOQ protein], Pioglitazone inhibits the reaction [Fructose results in decreased secretion of ADIPOQ protein] CTD PMID:24622831 , PMID:25679220 pioglitazone increases expression ISO RGD:1552054 6480464 pioglitazone results in increased expression of ADIPOQ mRNA, pioglitazone results in increased expression of ADIPOQ protein CTD PMID:12927809 more ... piperine multiple interactions ISO RGD:628748 6480464 piperine inhibits the reaction [Dietary Fats results in decreased expression of ADIPOQ protein] CTD PMID:25087745 pirinixic acid multiple interactions ISO RGD:1552054 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of ADIPOQ mRNA, [rosiglitazone co-treated with pirinixic acid] results in increased expression of ADIPOQ protein CTD PMID:16306350 , PMID:19710929 pirinixic acid increases expression ISO RGD:1552054 6480464 pirinixic acid results in increased expression of ADIPOQ mRNA, pirinixic acid results in increased expression of ADIPOQ protein CTD PMID:20558911 pluronic P-123 decreases secretion ISO RGD:628748 6480464 Poloxamer results in decreased secretion of ADIPOQ protein CTD PMID:29071762 pluronic P-123 multiple interactions ISO RGD:628748 6480464 carvacrol inhibits the reaction [Poloxamer results in decreased secretion of ADIPOQ protein] more ... CTD PMID:29071762 Poloxamer decreases secretion ISO RGD:628748 6480464 Poloxamer results in decreased secretion of ADIPOQ protein CTD PMID:29071762 Poloxamer multiple interactions ISO RGD:628748 6480464 carvacrol inhibits the reaction [Poloxamer results in decreased secretion of ADIPOQ protein] more ... CTD PMID:29071762 prednisone multiple interactions EXP 6480464 [Prednisone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of and results in increased secretion of ADIPOQ protein CTD PMID:29782964 prochloraz decreases expression EXP 6480464 prochloraz results in decreased expression of ADIPOQ mRNA CTD PMID:30879083 progesterone affects expression ISO RGD:1552054 6480464 Progesterone affects the expression of ADIPOQ mRNA CTD PMID:17251523 progesterone increases abundance ISO RGD:1552054 6480464 ADIPOQ protein results in increased abundance of Progesterone CTD PMID:27181934 progesterone multiple interactions EXP 6480464 ADIPOQ protein promotes the reaction [IGF1 protein results in increased abundance of Progesterone] CTD PMID:19081562 propylparaben increases expression ISO RGD:1552054 6480464 propylparaben results in increased expression of ADIPOQ mRNA CTD PMID:22956630 protein kinase inhibitor multiple interactions EXP 6480464 Protein Kinase Inhibitors inhibits the reaction [FASN protein results in increased expression of ADIPOQ mRNA] CTD PMID:26670611 protein kinase inhibitor decreases expression ISO RGD:1552054 6480464 Protein Kinase Inhibitors results in decreased expression of ADIPOQ mRNA CTD PMID:26670611 quercetin increases expression ISO RGD:628748 6480464 Quercetin results in increased expression of ADIPOQ protein CTD PMID:18551111 quercetin multiple interactions ISO RGD:628748 6480464 [Dietary Fats co-treated with Quercetin] affects the expression of ADIPOQ mRNA, Quercetin inhibits the reaction [Dietary Fats results in increased expression of ADIPOQ protein] CTD PMID:20580672 , PMID:24622831 quercetin multiple interactions ISO RGD:1552054 6480464 Quercetin inhibits the reaction [[Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of ADIPOQ protein], Quercetin inhibits the reaction [Dietary Fats results in decreased expression of ADIPOQ protein] CTD PMID:21462320 , PMID:24465016 raffinose increases secretion ISO RGD:1552054 6480464 Raffinose results in increased secretion of ADIPOQ protein CTD PMID:29458019 raloxifene increases expression ISO RGD:1552054 6480464 Raloxifene Hydrochloride results in increased expression of ADIPOQ mRNA CTD PMID:16643890 ramipril multiple interactions EXP 6480464 candesartan promotes the reaction [Ramipril results in increased expression of ADIPOQ], Ramipril promotes the reaction [candesartan results in increased expression of ADIPOQ] CTD PMID:17483542 ramipril decreases expression EXP 6480464 Ramipril results in decreased expression of ADIPOQ CTD PMID:17483542 ramipril increases expression EXP 6480464 Ramipril results in increased expression of ADIPOQ CTD PMID:17483542 , PMID:19059660 reactive oxygen species decreases abundance EXP 6480464 ADIPOQ protein results in decreased abundance of Reactive Oxygen Species CTD PMID:18931039 reactive oxygen species multiple interactions EXP 6480464 FTH1 protein affects the reaction [ADIPOQ protein results in decreased abundance of Reactive Oxygen Species], SOD2 protein affects the reaction [ADIPOQ protein results in decreased abundance of Reactive Oxygen Species] CTD PMID:18931039 resveratrol increases expression ISO RGD:1552054 6480464 resveratrol metabolite results in increased expression of ADIPOQ mRNA more ... CTD PMID:20980258 more ... resveratrol increases secretion ISO RGD:628748 6480464 resveratrol results in increased secretion of ADIPOQ protein CTD PMID:23824959 resveratrol increases expression ISO RGD:628748 6480464 resveratrol results in increased expression of ADIPOQ protein CTD PMID:19356108 more ... resveratrol increases expression EXP 6480464 resveratrol results in increased expression of ADIPOQ protein CTD PMID:23224687 resveratrol affects secretion EXP 6480464 resveratrol affects the secretion of ADIPOQ protein CTD PMID:24802182 resveratrol multiple interactions ISO RGD:628748 6480464 resveratrol inhibits the reaction [[Streptozocin co-treated with Niacinamide] results in decreased expression of ADIPOQ protein] more ... CTD PMID:21439372 more ... resveratrol multiple interactions EXP 6480464 resveratrol inhibits the reaction [IL1B protein results in decreased expression of ADIPOQ mRNA] CTD PMID:20531350 resveratrol decreases secretion ISO RGD:1552054 6480464 resveratrol results in decreased secretion of ADIPOQ protein CTD PMID:17452443 resveratrol multiple interactions ISO RGD:1552054 6480464 [Ethanol co-treated with Resveratrol] results in increased expression of ADIPOQ protein more ... CTD PMID:17374693 more ... retinyl acetate decreases expression ISO RGD:1552054 6480464 retinol acetate results in decreased expression of ADIPOQ mRNA CTD PMID:31449830 retinyl acetate multiple interactions ISO RGD:1552054 6480464 NR1I3 protein affects the reaction [retinol acetate results in decreased expression of ADIPOQ mRNA] CTD PMID:31449830 rimonabant increases expression ISO RGD:1552054 6480464 Rimonabant results in increased expression of ADIPOQ mRNA, Rimonabant results in increased expression of ADIPOQ protein CTD PMID:16282221 , PMID:20110567 risperidone multiple interactions ISO RGD:1552054 6480464 Berberine inhibits the reaction [Risperidone results in increased expression of ADIPOQ mRNA] CTD PMID:20564506 risperidone increases expression ISO RGD:1552054 6480464 Risperidone results in increased expression of ADIPOQ mRNA CTD PMID:20564506 ritonavir decreases expression ISO RGD:1552054 6480464 Ritonavir results in decreased expression of ADIPOQ mRNA, Ritonavir results in decreased expression of ADIPOQ protein CTD PMID:15865214 ritonavir multiple interactions ISO RGD:1552054 6480464 rosiglitazone inhibits the reaction [Ritonavir results in decreased secretion of ADIPOQ protein] CTD PMID:15865214 ritonavir decreases expression EXP 6480464 Ritonavir results in decreased expression of ADIPOQ protein CTD PMID:17668557 ritonavir multiple interactions EXP 6480464 diphenyleneiodonium inhibits the reaction [Ritonavir results in decreased expression of ADIPOQ protein] CTD PMID:17668557 Rutamarin multiple interactions ISO RGD:1552054 6480464 rutamarin promotes the reaction [Dietary Fats results in increased expression of ADIPOQ mRNA] CTD PMID:22384078 ruthenium red multiple interactions ISO RGD:1552054 6480464 Ruthenium Red inhibits the reaction [Olanzapine results in decreased expression of ADIPOQ protein] CTD PMID:32652086 salicylic acid multiple interactions ISO RGD:628748 6480464 Salicylic Acid inhibits the reaction [Palmitic Acid results in decreased expression of ADIPOQ mRNA] CTD PMID:25108154 sapropterin multiple interactions ISO RGD:628748 6480464 sapropterin inhibits the reaction [Fructose results in decreased expression of ADIPOQ mRNA], sapropterin inhibits the reaction [Fructose results in decreased expression of ADIPOQ protein] CTD PMID:17098227 saquinavir decreases expression ISO RGD:1552054 6480464 Saquinavir results in decreased expression of ADIPOQ mRNA, Saquinavir results in decreased expression of ADIPOQ protein CTD PMID:15865214 saquinavir multiple interactions ISO RGD:1552054 6480464 [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in decreased expression of ADIPOQ mRNA, rosiglitazone inhibits the reaction [Saquinavir results in decreased secretion of ADIPOQ protein] CTD PMID:15865214 , PMID:16931933 sarpogrelate increases expression EXP 6480464 sarpogrelate results in increased expression of ADIPOQ protein CTD PMID:18235151 SB 203580 increases expression ISO RGD:628748 6480464 SB 203580 results in increased expression of ADIPOQ mRNA CTD PMID:24412557 SB 203580 multiple interactions EXP 6480464 SB 203580 inhibits the reaction [ADIPOQ protein results in increased expression of CXCL1 protein], SB 203580 inhibits the reaction [ADIPOQ protein results in increased expression of CXCL8 protein] CTD PMID:28176455 SB 203580 increases secretion ISO RGD:628748 6480464 SB 203580 results in increased secretion of ADIPOQ protein CTD PMID:24412557 SB 203580 multiple interactions ISO RGD:628748 6480464 SB 203580 inhibits the reaction [Ethanol results in decreased secretion of ADIPOQ protein] CTD PMID:24412557 scopoletin multiple interactions ISO RGD:628748 6480464 Scopoletin inhibits the reaction [Ethanol results in decreased expression of ADIPOQ mRNA], Scopoletin inhibits the reaction [Ethanol results in decreased expression of ADIPOQ protein] CTD PMID:26115886 serpentine asbestos decreases expression ISO RGD:1552054 6480464 Asbestos, Serpentine results in decreased expression of ADIPOQ mRNA CTD PMID:23917077 sildenafil citrate increases expression ISO RGD:1552054 6480464 Sildenafil Citrate results in increased expression of ADIPOQ mRNA CTD PMID:20471953 silicon dioxide decreases expression ISO RGD:1552054 6480464 Silicon Dioxide results in decreased expression of ADIPOQ mRNA CTD PMID:29341224 simvastatin multiple interactions ISO RGD:1552054 6480464 Simvastatin promotes the reaction [Lipopolysaccharides results in increased expression of ADIPOQ mRNA], Simvastatin promotes the reaction [Lipopolysaccharides results in increased secretion of ADIPOQ protein] CTD PMID:17641834 simvastatin multiple interactions ISO RGD:628748 6480464 carvacrol promotes the reaction [Simvastatin inhibits the reaction [Poloxamer results in decreased secretion of ADIPOQ protein]], Simvastatin inhibits the reaction [Poloxamer results in decreased secretion of ADIPOQ protein] CTD PMID:29071762 sodium arsenite multiple interactions EXP 6480464 BQ 610 affects the reaction [sodium arsenite inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of ADIPOQ mRNA]] more ... CTD PMID:23152186 , PMID:23650128 sodium arsenite decreases expression ISO RGD:1552054 6480464 sodium arsenite results in decreased expression of ADIPOQ protein CTD PMID:29755549 sodium arsenite increases expression ISO RGD:1552054 6480464 sodium arsenite results in increased expression of ADIPOQ mRNA, sodium arsenite results in increased expression of ADIPOQ protein CTD PMID:28593471 , PMID:31170414 sodium arsenite multiple interactions ISO RGD:1552054 6480464 sodium arsenite inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ mRNA] more ... CTD PMID:23152186 more ... sodium arsenite affects expression ISO RGD:1552054 6480464 sodium arsenite affects the expression of ADIPOQ, sodium arsenite affects the expression of ADIPOQ mRNA CTD PMID:25367288 , PMID:28206643 sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of ADIPOQ mRNA CTD PMID:23650128 Sodium oleate multiple interactions EXP 6480464 3-4-chlorophenyl-N-methyl-N'-4-chlorophenylsulfonyl-4-phenyl-4 more ... CTD PMID:31454063 spironolactone multiple interactions EXP 6480464 Spironolactone inhibits the reaction [[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of and results in increased secretion of ADIPOQ protein] CTD PMID:29782964 stavudine decreases expression EXP 6480464 Stavudine results in decreased expression of ADIPOQ protein CTD PMID:17668557 stavudine decreases expression ISO RGD:1552054 6480464 Stavudine results in decreased expression of ADIPOQ mRNA, Stavudine results in decreased expression of ADIPOQ protein CTD PMID:15865214 , PMID:17503663 stilben-4-ol increases expression ISO RGD:1552054 6480464 4-hydroxystilbene results in increased expression of ADIPOQ mRNA CTD PMID:23748787 streptozocin multiple interactions ISO RGD:628748 6480464 [Dietary Fats co-treated with Streptozocin] results in decreased expression of ADIPOQ protein more ... CTD PMID:21439372 more ... streptozocin multiple interactions ISO RGD:1552054 6480464 [Dietary Fats co-treated with Streptozocin] results in decreased expression of and results in decreased secretion of ADIPOQ protein more ... CTD PMID:29988851 , PMID:32410268 streptozocin decreases expression ISO RGD:628748 6480464 Streptozocin results in decreased expression of ADIPOQ mRNA, Streptozocin results in decreased expression of ADIPOQ protein CTD PMID:17270171 more ... sulforaphane increases expression ISO RGD:1552054 6480464 sulforaphane results in increased expression of ADIPOQ mRNA CTD PMID:30529165 telmisartan increases expression ISO RGD:1552054 6480464 telmisartan results in increased expression of ADIPOQ mRNA CTD PMID:19730415 telmisartan increases expression EXP 6480464 telmisartan results in increased expression of ADIPOQ protein CTD PMID:20555330 Tesaglitazar decreases expression ISO RGD:628748 6480464 tesaglitazar results in decreased expression of ADIPOQ mRNA CTD PMID:21515302 testosterone decreases expression EXP 6480464 Testosterone results in decreased expression of ADIPOQ CTD PMID:16793964 testosterone decreases abundance ISO RGD:628748 6480464 ADIPOQ protein results in decreased abundance of Testosterone CTD PMID:24472609 testosterone multiple interactions ISO RGD:628748 6480464 [bisphenol A co-treated with Testosterone] results in decreased expression of ADIPOQ mRNA, ADIPOQ protein inhibits the reaction [LHB protein results in increased chemical synthesis of Testosterone] CTD PMID:22155228 , PMID:26496021 testosterone decreases chemical synthesis ISO RGD:628748 6480464 ADIPOQ protein results in decreased chemical synthesis of Testosterone CTD PMID:22155228 tetrachloromethane multiple interactions ISO RGD:1552054 6480464 ADIPOQ protein affects the reaction [Carbon Tetrachloride results in increased expression of CCN2 mRNA], ADIPOQ protein affects the reaction [Carbon Tetrachloride results in increased expression of TGFB1 mRNA] CTD PMID:14724832 tetrachloromethane decreases expression ISO RGD:628748 6480464 Carbon Tetrachloride results in decreased expression of ADIPOQ mRNA CTD PMID:31150632 tetrachloromethane multiple interactions ISO RGD:628748 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of ADIPOQ mRNA] CTD PMID:31150632 tetrachloromethane decreases expression ISO RGD:1552054 6480464 Carbon Tetrachloride results in decreased expression of ADIPOQ protein CTD PMID:14724832 Thiocarbohydrazide multiple interactions EXP 6480464 thiocarbohydrazide inhibits the reaction [[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of and results in increased secretion of ADIPOQ protein] CTD PMID:29782964 titanium dioxide decreases expression ISO RGD:1552054 6480464 titanium dioxide results in decreased expression of ADIPOQ mRNA CTD PMID:23131501 , PMID:23557971 toluene increases methylation EXP 6480464 Toluene results in increased methylation of ADIPOQ gene CTD PMID:26717081 toluene decreases expression EXP 6480464 Toluene results in decreased expression of ADIPOQ mRNA CTD PMID:26717081 tolylfluanid multiple interactions EXP 6480464 N-dichlorofluoromethylthio-N', N'-dimethyl-N-p-tolylsulfamide inhibits the reaction [[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of and results in increased secretion of ADIPOQ protein] CTD PMID:29782964 topiramate increases expression ISO RGD:1552054 6480464 topiramate results in increased expression of ADIPOQ mRNA CTD PMID:12927809 topiramate increases secretion ISO RGD:1552054 6480464 topiramate results in increased secretion of ADIPOQ protein CTD PMID:12927809 triamcinolone multiple interactions EXP 6480464 [Triamcinolone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of and results in increased secretion of ADIPOQ protein CTD PMID:29782964 tributylstannane multiple interactions ISO RGD:1552054 6480464 tributyltin promotes the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of ADIPOQ mRNA] CTD PMID:22197818 tributylstannane decreases expression ISO RGD:1552054 6480464 tributyltin results in decreased expression of ADIPOQ protein CTD PMID:30172001 tributylstannane decreases expression ISO RGD:628748 6480464 tributyltin results in decreased expression of ADIPOQ protein CTD PMID:30172001 tributylstannane decreases secretion ISO RGD:1552054 6480464 tributyltin results in decreased secretion of ADIPOQ protein CTD PMID:29675927 tributylstannane multiple interactions EXP 6480464 tributyltin promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased secretion of ADIPOQ protein], tributyltin promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ protein] CTD PMID:31016361 , PMID:32407875 tributylstannane affects expression ISO RGD:1552054 6480464 tributyltin affects the expression of ADIPOQ protein CTD PMID:28397090 tributylstannane decreases secretion ISO RGD:628748 6480464 tributyltin results in decreased secretion of ADIPOQ protein CTD PMID:28161095 tributylstannane increases expression ISO RGD:1552054 6480464 tributyltin results in increased expression of ADIPOQ mRNA CTD PMID:23428407 trichloroethene decreases expression ISO RGD:1552054 6480464 Trichloroethylene results in decreased expression of ADIPOQ mRNA CTD PMID:29669109 trichloroethene multiple interactions ISO RGD:1552054 6480464 [Trichloroethylene co-treated with Dietary Fats] results in decreased expression of ADIPOQ mRNA CTD PMID:29669109 triclosan decreases expression EXP 6480464 Triclosan results in decreased expression of ADIPOQ mRNA CTD PMID:22726953 triflumizole multiple interactions EXP 6480464 [triflumizol co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with Indomethacin co-treated with INS protein] results in increased expression of ADIPOQ mRNA CTD PMID:23086663 triflumizole multiple interactions ISO RGD:1552054 6480464 [triflumizol co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of ADIPOQ mRNA CTD PMID:23086663 triflumizole increases expression ISO RGD:1552054 6480464 triflumizol results in increased expression of ADIPOQ mRNA CTD PMID:23086663 triphenyl phosphate increases expression EXP 6480464 triphenyl phosphate results in increased expression of ADIPOQ mRNA CTD PMID:28934090 triptonide increases expression ISO RGD:1552054 6480464 triptonide results in increased expression of ADIPOQ mRNA CTD PMID:33045310 troglitazone increases expression EXP 6480464 Troglitazone results in increased expression of ADIPOQ mRNA, Troglitazone results in increased expression of ADIPOQ protein CTD PMID:16076985 , PMID:28934090 troglitazone decreases expression ISO RGD:628748 6480464 troglitazone results in decreased expression of ADIPOQ mRNA CTD PMID:21515302 troglitazone decreases expression ISO RGD:1552054 6480464 troglitazone results in decreased expression of ADIPOQ mRNA CTD PMID:12732648 troglitazone increases secretion ISO RGD:1552054 6480464 troglitazone results in increased secretion of ADIPOQ protein CTD PMID:17452443 tungsten increases expression ISO RGD:1552054 6480464 Tungsten results in increased expression of ADIPOQ mRNA CTD PMID:26865663 tungsten multiple interactions ISO RGD:1552054 6480464 Tungsten promotes the reaction [rosiglitazone results in increased expression of ADIPOQ mRNA] CTD PMID:26865663 tunicamycin increases expression ISO RGD:1552054 6480464 Tunicamycin results in increased expression of ADIPOQ mRNA CTD PMID:17127020 umbelliferone multiple interactions ISO RGD:1552054 6480464 7-hydroxycoumarin inhibits the reaction [Dietary Fats results in decreased expression of ADIPOQ protein] CTD PMID:24661945 valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of ADIPOQ protein CTD PMID:19085528 vanadium atom multiple interactions ISO RGD:1552054 6480464 NL-71-101 inhibits the reaction [Vanadium results in increased expression of ADIPOQ protein], Vanadium results in increased expression of and results in increased secretion of ADIPOQ protein CTD PMID:16524741 vanadium(0) multiple interactions ISO RGD:1552054 6480464 NL-71-101 inhibits the reaction [Vanadium results in increased expression of ADIPOQ protein], Vanadium results in increased expression of and results in increased secretion of ADIPOQ protein CTD PMID:16524741 vanadyl sulfate multiple interactions ISO RGD:1552054 6480464 NL-71-101 inhibits the reaction [vanadyl sulfate results in increased expression of ADIPOQ protein], vanadyl sulfate results in increased expression of and results in increased secretion of ADIPOQ protein CTD PMID:16524741 vinclozolin increases expression ISO RGD:628748 6480464 vinclozolin results in increased expression of ADIPOQ mRNA CTD PMID:23869203 vitamin E multiple interactions ISO RGD:628748 6480464 Vitamin E inhibits the reaction [Dietary Fats results in decreased expression of ADIPOQ mRNA], Vitamin E inhibits the reaction [Dietary Fats results in decreased expression of ADIPOQ protein] CTD PMID:20404018 warfarin increases expression ISO RGD:628748 6480464 Warfarin results in increased expression of ADIPOQ protein CTD PMID:27488359 warfarin multiple interactions ISO RGD:628748 6480464 Warfarin inhibits the reaction [[Dietary Fats co-treated with Streptozocin] results in decreased expression of ADIPOQ protein] CTD PMID:27488359 XL147 multiple interactions ISO RGD:1552054 6480464 [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of ADIPOQ mRNA CTD PMID:27935865 zidovudine decreases expression EXP 6480464 Zidovudine results in decreased expression of ADIPOQ protein CTD PMID:17668557 zidovudine decreases expression ISO RGD:1552054 6480464 Zidovudine results in decreased expression of ADIPOQ mRNA, Zidovudine results in decreased expression of ADIPOQ protein CTD PMID:15865214 , PMID:17503663 zidovudine multiple interactions ISO RGD:1552054 6480464 [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in decreased expression of ADIPOQ mRNA CTD PMID:16931933 zinc molecular entity multiple interactions ISO RGD:628748 6480464 Zinc Compounds inhibits the reaction [[Streptozocin co-treated with Dietary Fats] results in decreased expression of ADIPOQ protein] CTD PMID:24854284 zinc protoporphyrin multiple interactions ISO RGD:1552054 6480464 zinc protoporphyrin inhibits the reaction [ADIPOQ protein inhibits the reaction [Lipopolysaccharides results in increased expression of CXCL10 mRNA]], zinc protoporphyrin inhibits the reaction [ADIPOQ protein inhibits the reaction [Lipopolysaccharides results in increased expression of IFNB1 mRNA]] CTD PMID:20861358 zinc protoporphyrin multiple interactions ISO RGD:628748 6480464 zinc protoporphyrin inhibits the reaction [ADIPOQ protein inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]] CTD PMID:20052772